Please login to the form below

Not currently logged in
Email:
Password:

EMA’s Paediatric Committee elects new leaders

Dirk Mentzer and Henk van den Berg elected as chair and vice-chair

Dirk Mentzer The European Medicines Agency's (EMA) Paediatric Committee (PDCO) last week elected Dirk Mentzer and Henk van den Berg chair and vice-chair, respectively, at its September meeting. Both have been elected for a three-year term. 

A paediatrician by training, Dr Mentzer is currently head of the pharmacovigilance unit at the Paul-Ehrlich Institut in Frankfurt, Germany.  He is an expert in paediatric specialist training, including neonatology and paediatric accident and emergency admissions. 

Dr Van den Berg is a consultant in paediatric haematology / oncology at the Medicines Evaluation Board in Utrecht, the Netherlands.  His areas of expertise include paediatric haematology, clinical pharmacology and medical education. 

On their election, Mentzer and van den Berg thanked outgoing chair Daniel Brasseur, who has left the PDCO to become a member of the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).

Both Mentzer and van den Berg have been members of the PDCO since it was established in 2007. The committee's main role is to assess the content of paediatric investigation plans (PIPS). It meets for three days each month at the EMA in London.

19th September 2013

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....